Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Man...

FDA Recall #D-0097-2021 — Class II — October 26, 2020

Recall #D-0097-2021 Date: October 26, 2020 Classification: Class II Status: Terminated

Product Description

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01

Reason for Recall

Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.

Recalling Firm

Ascent Pharmaceuticals, Inc. — Central Islip, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

9768 Bottles

Distribution

Nationwide within the United States

Code Information

Lot #: 20070518, Exp. Date June 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated